rs375116558
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 0P and 3B. BP4_ModerateBP6
The NM_000256.3(MYBPC3):āc.3384G>Cā(p.Glu1128Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000247 in 1,610,176 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000256.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYBPC3 | ENST00000545968.6 | c.3384G>C | p.Glu1128Asp | missense_variant | Exon 31 of 35 | 5 | NM_000256.3 | ENSP00000442795.1 | ||
MYBPC3 | ENST00000399249.6 | c.3384G>C | p.Glu1128Asp | missense_variant | Exon 30 of 34 | 5 | ENSP00000382193.2 |
Frequencies
GnomAD3 genomes AF: 0.0000789 AC: 12AN: 152180Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000910 AC: 22AN: 241694Hom.: 0 AF XY: 0.000130 AC XY: 17AN XY: 131244
GnomAD4 exome AF: 0.000264 AC: 385AN: 1457996Hom.: 0 Cov.: 35 AF XY: 0.000263 AC XY: 191AN XY: 724884
GnomAD4 genome AF: 0.0000789 AC: 12AN: 152180Hom.: 0 Cov.: 33 AF XY: 0.0000942 AC XY: 7AN XY: 74340
ClinVar
Submissions by phenotype
not specified Uncertain:1
Variant classified as Uncertain Significance - Favor Benign. The p.Glu1128Asp va riant in MYBPC3 has been identified in 1 individual with DCM (Gable 2014) and 1 individual with HCM (LMM data), but has also been identified in 0.017% (21/12346 6) of European chromosomes by the Genome Aggregation Database (gnomAD, http://gn omad.broadinstitute.org; dbSNP rs375116558). It has been reported in ClinVar (Va riant ID:42710). Computational prediction tools and conservation analysis sugges t that the p.Glu1128Asp variant may not impact the protein, though this informat ion is not predictive enough to rule out pathogenicity. In summary, while the c linical significance of the p.Glu1128Asp variant is uncertain, these data sugges t that it is more likely to be benign. ACMG/AMP criteria applied: BP4. -
Cardiomyopathy Uncertain:1
This missense variant replaces glutamic acid with aspartic acid at codon 1128 of the MYBPC3 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in an individual affected with hypertrophic cardiomyopathy (PMID: 25611685), an individual affected with dilated cardiomyopathy (doi:10.1136/heartjnl-2016-309890.210), and in a case of sudden unexplained death (PMID: 27930701). This variant has been identified in 23/273044 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
not provided Uncertain:1
A variant of uncertain significance has been identified in the MYBPC3 gene. The E1128D variant has not been published as pathogenic or been reported as benign to our knowledge. This variant is observed in 21/123466 (0.02%) alleles from individuals of European (non-Finnish) ancestry in large population cohorts (Lek et al., 2016). The E1128D variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. Finally, in-silico analyses, including protein predictors and evolutionary conservation, support that this variant does not alter protein structure/function. Therefore, based on the currently available information, it is unclear whether this variant is pathogenic or rare benign. -
Hypertrophic cardiomyopathy Benign:1
- -
Cardiovascular phenotype Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at